PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
6 hedge funds and large institutions have $1.22M invested in PAVmed Inc. Series Z Warrant in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
30% less capital invested
Capital invested by funds: $1.74M → $1.22M (-$517K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$9.16K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$375 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$104K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $949K | -$104K | -305,700 | -9% |
|
|
LCS
2
Levin Capital Strategies
New York
| $208K | +$9.16K | +26,900 | +4% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $35K | -$14K | -41,050 | -27% |
|
|
MRCM
4
M&R Capital Management
Summit,
New Jersey
| $26K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $5K | +$375 | +1,100 | +8% |
|
PAVMZ Hedge Fund Activity: Q3 2019 in Review
6 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q3 2019, worth a combined $1.22M — down 30% from $1.74M a quarter earlier.
Fund positioning in PAVMZ was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $9.16K. The largest seller was Sabby Management, cutting an estimated $104K.
- 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $1.22M of PAVmed Inc. Series Z Warrant stock for Q3 2019, down 30% quarter-over-quarter.
- 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q3 2019 and 0 closed out.
- The largest PAVmed Inc. Series Z Warrant buyer in Q3 2019 was Levin Capital Strategies, an estimated $9.16K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q3 2019 was Sabby Management, an estimated $104K sold.
Based on aggregated 13F filings for Q3 2019.